Literature DB >> 29259734

Chemical Compounds as Inhibitors of Kinase Activity for the Treatment of Cancer and COPD.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2017        PMID: 29259734      PMCID: PMC5733274          DOI: 10.1021/acsmedchemlett.7b00448

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

1.  Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.

Authors:  Mariaelena Pierobon; Corinne Ramos; Shukmei Wong; K Alex Hodge; Jessica Aldrich; Sara Byron; Stephen P Anthony; Nicholas J Robert; Donald W Northfelt; Mohammad Jahanzeb; Linda Vocila; Julia Wulfkuhle; Guido Gambara; Rosa I Gallagher; Bryant Dunetz; Nicholas Hoke; Ting Dong; David W Craig; Massimo Cristofanilli; Brian Leyland-Jones; Lance A Liotta; Joyce A O'Shaughnessy; John D Carpten; Emanuel F Petricoin
Journal:  Clin Cancer Res       Date:  2017-04-26       Impact factor: 12.531

2.  MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.

Authors:  Satyendra C Tripathi; Johannes F Fahrmann; Muge Celiktas; Mitzi Aguilar; Kieren D Marini; Mohit K Jolly; Hiroyuki Katayama; Hong Wang; Eunice N Murage; Jennifer B Dennison; D Neil Watkins; Herbert Levine; Edwin J Ostrin; Ayumu Taguchi; Samir M Hanash
Journal:  Cancer Res       Date:  2017-06-23       Impact factor: 12.701

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.